Kahook Dual Blade: Definition, Uses, and Clinical Overview

Kahook Dual Blade Introduction (What it is)

Kahook Dual Blade is a single-use microsurgical blade used in glaucoma surgery.
It is designed to remove a strip of tissue from the eye’s internal drainage pathway.
It is most commonly used during minimally invasive glaucoma surgery (MIGS).
It may be performed alone or combined with cataract surgery in appropriate cases.

Why Kahook Dual Blade used (Purpose / benefits)

Kahook Dual Blade is used to help lower intraocular pressure (IOP), the fluid pressure inside the eye. Elevated IOP is a major risk factor for glaucoma, a group of diseases that can damage the optic nerve and reduce vision over time. Many glaucoma treatments aim to improve the eye’s ability to drain fluid (aqueous humor) or reduce how much fluid the eye produces.

The Kahook Dual Blade is intended to improve fluid outflow through the eye’s natural drainage system by removing a portion of the trabecular meshwork (a thin, sieve-like tissue). In many people with open-angle glaucoma, resistance to outflow is believed to occur at or near the trabecular meshwork and the inner wall of Schlemm’s canal (a circular channel that helps collect and route fluid out of the eye).

Potential benefits that clinicians may seek with Kahook Dual Blade include:

• Lowering IOP to reduce risk of glaucoma progression
• Reducing dependence on glaucoma eye drops for some patients (varies by clinician and case)
• Using an “ab interno” approach (from inside the eye) that does not create an external filtering bleb, unlike traditional trabeculectomy
• Combining glaucoma and cataract treatment in a single operative session for selected patients

It is important to understand that outcomes can vary based on glaucoma type, severity, eye anatomy, healing response, and whether other procedures are performed at the same time.

Indications (When ophthalmologists or optometrists use it)

Kahook Dual Blade is typically considered in scenarios such as:

• Primary open-angle glaucoma, often mild to moderate in severity (varies by clinician and case)
• Ocular hypertension when pressure lowering is needed and the angle anatomy is suitable
• Patients undergoing cataract surgery who also need glaucoma pressure management (combined “phaco + MIGS” approach)
• Patients who have difficulty tolerating, adhering to, or affording multiple glaucoma medications (context-dependent)
• Patients in whom a bleb-forming procedure is not desired or not appropriate at that time
• Selected cases of other open-angle glaucomas where angle-based procedures are considered (case selection varies)

Optometrists do not perform Kahook Dual Blade surgery, but they may co-manage glaucoma care, help identify candidates for referral, and monitor postoperative ocular health under an ophthalmologist’s plan.

Contraindications / when it’s NOT ideal

Kahook Dual Blade is not ideal for every glaucoma patient or every eye. Situations where it may be less suitable, technically difficult, or less effective include:

• Angle-closure glaucoma where the drainage angle is closed or not accessible for angle surgery
• Extensive peripheral anterior synechiae (PAS), meaning scar-like adhesions that block the angle structures
• Poor visibility of the drainage angle (for example, due to corneal opacity or other media issues) that prevents safe gonioscopic visualization
• Neovascular glaucoma (abnormal new blood vessels in the angle), where bleeding and scarring risks may be higher and alternative strategies are often considered
• Active or poorly controlled intraocular inflammation (uveitis) in some cases, depending on the clinical situation
• Eyes where a much lower target IOP is required than angle-based surgery typically achieves, leading some clinicians to favor traditional filtration surgery or tube shunts (varies by clinician and case)
• Significant scarring or structural damage in the conventional outflow pathway that limits the benefit of trabecular tissue removal

Final suitability is individualized and depends on anatomy, glaucoma mechanism, prior surgeries, and the clinician’s experience and treatment goals.

How it works (Mechanism / physiology)

Mechanism of action

Kahook Dual Blade is used to perform an excisional goniotomy (also described as trabecular meshwork excision). In simplified terms, it “opens” part of the eye’s clogged drain by removing a strip of the tissue that can contribute to outflow resistance.

Unlike a stent that stays in the eye, Kahook Dual Blade is a surgical instrument used during the procedure and then removed. The tissue excision it creates is not intended to be reversible, although healing responses and long-term patency (how open the pathway remains) can vary.

Relevant anatomy (explained simply)

To understand the goal, it helps to know the basic fluid pathway:

• Aqueous humor: clear fluid made inside the eye that nourishes internal tissues
• Trabecular meshwork: the primary “filter” or outflow tissue near where the cornea and iris meet (the drainage angle)
• Schlemm’s canal: a circular collection channel just beyond the trabecular meshwork
• Collector channels and episcleral veins: downstream pathways that carry fluid back into the bloodstream

In many open-angle glaucomas, the drainage angle is physically “open,” but the fluid still does not exit efficiently. By removing a portion of trabecular meshwork, the procedure aims to reduce resistance at this key bottleneck.

Onset and duration (what’s relevant here)

Because Kahook Dual Blade is part of a surgical intervention, the IOP effect—when achieved—often begins during the early postoperative period as the eye heals. The durability of pressure lowering can vary by clinician and case. Long-term outcomes depend on factors such as healing/scarring, the health of downstream drainage channels, and whether additional glaucoma treatments are needed over time.

Kahook Dual Blade Procedure overview (How it’s applied)

Kahook Dual Blade is not a “treatment you use at home.” It is a surgical tool used by an ophthalmologist in an operating room or ambulatory surgery center. A high-level workflow often includes:

1. Evaluation / exam
   The clinician assesses glaucoma type and severity, current IOP control, optic nerve status, visual field results, and angle anatomy (commonly with gonioscopy, a method for viewing the drainage angle). Candidacy for MIGS is determined by multiple factors, including whether cataract surgery is also planned.

2. Preparation
   Surgery is typically performed under local anesthesia with sedation or other anesthesia approaches depending on patient factors and setting. The eye is prepared in a sterile fashion.

3. Intervention (Kahook Dual Blade use)
   The surgeon accesses the inside of the eye through a small corneal incision and uses a special viewing lens to see the drainage angle. The Kahook Dual Blade is then used to excise a strip of trabecular meshwork over a targeted arc, creating a more direct pathway for aqueous humor into Schlemm’s canal.

4. Immediate checks
   The surgeon checks the eye’s stability, evaluates the surgical site, and confirms that no unexpected issues are present. A small amount of blood reflux from the canal into the anterior chamber can occur and is often anticipated with angle procedures.

5. Follow-up
   Postoperative visits monitor IOP, inflammation, corneal clarity, and overall healing. Medication plans and activity guidance vary by clinician and case.

This overview intentionally avoids step-by-step surgical instruction; exact technique details are specific to surgical training, equipment, and individual anatomy.

Types / variations

Kahook Dual Blade refers to a specific family of dual-edged blades designed for trabecular meshwork excision. Variations in real-world use are often less about “types of Kahook Dual Blade” and more about how the tool is incorporated into a surgical plan. Common variations include:

• Standalone Kahook Dual Blade goniotomy
  Performed as a MIGS procedure without cataract surgery, typically in phakic (natural lens) or pseudophakic (intraocular lens) eyes depending on case selection.

• Combined cataract surgery + Kahook Dual Blade
  Often performed during the same session as phacoemulsification with intraocular lens implantation. The combined approach aims to address both cataract-related blur and glaucoma pressure management in one operation, when appropriate.

• Extent of treatment (arc length)
  Surgeons may treat different amounts of trabecular meshwork based on anatomy and goals. The specific extent is a technical decision and varies by clinician and case.

• Device iterations
  Manufacturers may offer updated designs (for example, versions intended to glide more smoothly through tissue). Exact availability and naming can vary by market and over time.

• Combination with other MIGS
  Some surgical plans include Kahook Dual Blade alongside other angle or outflow-enhancing procedures, depending on the desired pressure target and the eye’s characteristics.

Pros and cons

Pros

• Uses an internal (ab interno) approach that preserves the outer conjunctiva, which may matter for future surgical options
• Targets the conventional outflow pathway rather than creating an external bleb
• Can be combined with cataract surgery in selected patients
• Does not leave an implanted stent in the eye (the blade is removed after use)
• Typically involves small incisions associated with MIGS approaches
• May reduce medication burden for some patients (varies by clinician and case)

Cons

• IOP lowering may be limited by downstream outflow resistance (for example, episcleral venous pressure and collector channel function)
• Not ideal for eyes with poor angle access/visibility or extensive scarring/closure of the angle
• Postoperative bleeding in the front of the eye (hyphema) can occur and may temporarily blur vision
• IOP fluctuations can occur in the early healing period; monitoring is needed
• Some patients still require glaucoma drops, laser, or additional surgery afterward (varies by clinician and case)
• As with any intraocular surgery, risks such as inflammation, infection, or damage to nearby structures exist, though rates vary and depend on many factors

Aftercare & longevity

Aftercare following a Kahook Dual Blade procedure is focused on monitoring healing and ensuring the eye maintains safe pressure and clear vision. While specific medication regimens and restrictions are individualized, follow-up typically evaluates:

• IOP trends: pressure can change as the eye heals, and clinicians watch for spikes or insufficient lowering
• Inflammation control: mild inflammation is common after intraocular procedures; management varies by clinician and case
• Clarity of the cornea and anterior chamber: temporary haze, irritation, or light sensitivity may occur
• Presence and resolution of hyphema: small amounts of blood can settle and then clear over time
• Optic nerve and visual field stability over time: glaucoma care remains longitudinal, regardless of the procedure

Longevity of the IOP-lowering effect depends on multiple factors:

• Glaucoma type and severity: advanced disease may require lower target pressures than angle surgery typically achieves
• Angle anatomy and scarring response: healing can partially re-establish resistance in some eyes
• Downstream drainage system health: even with trabecular tissue removed, fluid must still exit via collector channels and veins
• Medication use and follow-up adherence: ongoing glaucoma management often includes continued monitoring and, in some cases, additional therapies
• Comorbidities: diabetes, inflammatory eye disease, prior surgeries, and other factors can influence healing (varies by clinician and case)

This is informational only; timing of visits, medication changes, and activity guidance should come from the treating clinician.

Alternatives / comparisons

Kahook Dual Blade is one option within a broad glaucoma treatment spectrum. Comparisons are best made in terms of goals (pressure level needed), mechanism (how pressure is lowered), and trade-offs (risk profile, recovery, and long-term management needs).

• Observation / monitoring
  For glaucoma suspects or very early disease, clinicians may prioritize monitoring over immediate intervention, depending on risk factors and progression evidence.

• Medications (eye drops or oral agents in selected cases)
  Drops can lower IOP by decreasing aqueous production or increasing outflow. They avoid surgery but can be limited by side effects, adherence challenges, cost, and the need for multiple daily doses.

• Laser trabeculoplasty (for open-angle glaucoma)
  Selective laser trabeculoplasty (SLT) and related approaches aim to improve trabecular outflow without incisions. Laser is often considered earlier in the treatment pathway for suitable open-angle cases, with effects that can diminish over time (varies by clinician and case).

• Other MIGS (angle-based or outflow-enhancing)
  Options include trabecular micro-bypass stents, scaffold devices, trabeculotomy-based techniques (such as canal-based procedures), and other goniotomy tools. Compared with implant-based MIGS, Kahook Dual Blade does not leave a device behind; compared with some canal-based procedures, the mechanisms and technical steps differ.

• Trabeculectomy and tube shunts (traditional filtering surgeries)
  These procedures create alternative drainage pathways and can achieve lower IOP targets in many cases, but they typically involve more intensive follow-up and different risk profiles, including bleb-related issues.

• Cyclodestructive procedures
  Some treatments reduce aqueous production by treating the ciliary body (often with laser). These are generally considered in specific scenarios and are selected based on disease stage and overall clinical context.

The “best” choice is individualized. Clinicians weigh glaucoma severity, rate of progression, anatomy, lens status (cataract presence), prior procedures, and the desired target IOP.

Kahook Dual Blade Common questions (FAQ)

Q: Is Kahook Dual Blade a type of laser treatment?
No. Kahook Dual Blade is a surgical instrument used inside the eye to remove a strip of trabecular meshwork. Laser treatments for glaucoma (such as SLT) work by applying laser energy to tissue rather than excising it.

Q: Does the Kahook Dual Blade stay in the eye like a stent?
No. The Kahook Dual Blade is used during surgery and then removed. The goal is to create a lasting opening by excising tissue, not to implant a permanent device.

Q: What condition is Kahook Dual Blade most commonly used for?
It is most commonly used as part of MIGS for open-angle glaucoma and related conditions where improving trabecular outflow is expected to help lower IOP. Suitability depends on angle anatomy and clinical goals.

Q: Will it improve vision?
The procedure is aimed at pressure control, not directly at sharpening vision. If it is done at the same time as cataract surgery, vision may improve from cataract removal, while the glaucoma portion targets IOP management.

Q: Is the procedure painful?
Many patients report limited pain during the procedure due to anesthesia, though sensations like pressure or mild discomfort can occur. Afterward, irritation, scratchiness, or light sensitivity may happen during healing, and experiences vary by clinician and case.

Q: How long does it take to recover?
Recovery timelines vary depending on whether the procedure is combined with cataract surgery, how much inflammation occurs, and individual healing response. Vision can be temporarily blurry, especially if there is postoperative blood in the front of the eye, and follow-up visits are used to track normalization.

Q: How long do the pressure-lowering results last?
Durability varies by clinician and case. Some patients maintain meaningful IOP reduction long term, while others may need additional medications, laser, or surgery as glaucoma is a chronic disease with an ongoing management timeline.

Q: Is Kahook Dual Blade considered safe?
It is widely used within the MIGS category, but “safe” is relative and depends on patient factors, surgeon experience, and eye anatomy. Like any intraocular surgery, it carries risks such as bleeding, inflammation, infection, and pressure changes; the exact risk profile varies.

Q: Will I still need glaucoma drops afterward?
Some patients continue the same drops, some reduce medications, and others may stop certain drops under clinician supervision—outcomes vary by clinician and case. The procedure is often framed as a way to help reach IOP goals, not a guaranteed replacement for medication.

Q: Can I drive or return to screens soon after surgery?
Driving depends on vision clarity, comfort, legal requirements, and whether sedation was used; clinicians commonly caution against driving immediately after surgery day. Screen use is often possible as comfort allows, but temporary blur, light sensitivity, or dryness may limit it early on; individualized guidance comes from the treating team.

Q: How much does Kahook Dual Blade surgery cost?
Costs vary widely by country, surgical setting, insurance coverage, and whether it is combined with cataract surgery. Facility fees, professional fees, anesthesia, and postoperative care policies can all affect overall cost, so pricing is typically discussed with the clinic and insurer.